Recent ADVM News
- Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/20/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2024 09:05:45 PM
- Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements • GlobeNewswire Inc. • 11/18/2024 12:00:00 PM
- Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements • GlobeNewswire Inc. • 11/15/2024 09:05:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 11:57:12 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 11:40:56 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:05:12 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/08/2024 07:17:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2024 09:44:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 09:42:51 PM
- Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones • GlobeNewswire Inc. • 11/04/2024 09:39:45 PM
- Adverum Biotechnologies Appoints Jason L. Mitchell as Chief Commercial Officer as it Prepares to Initiate Pivotal Program • GlobeNewswire Inc. • 10/16/2024 12:00:00 PM
- Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/05/2024 11:30:00 AM
- Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences • GlobeNewswire Inc. • 09/04/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:10:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:08:24 PM
- Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights • GlobeNewswire Inc. • 08/12/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:10:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:09:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:09:00 PM
- Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference • GlobeNewswire Inc. • 08/02/2024 11:00:00 AM
- Adverum Biotechnologies Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for Ixo-vec for the Treatment of Wet AMD • GlobeNewswire Inc. • 08/01/2024 12:00:00 PM
Critical Metals Surge Opens Prime Opportunity for Mining Investors • PLG • Nov 22, 2024 8:30 AM
ILUS Agrees to Swap Majority Stake in Quality Industrial Corp. for Future Majority Stake in Fusion Fuel Green (NASDAQ: HTOO) • ILUS • Nov 20, 2024 9:07 AM
Avant Technologies and Ainnova Advancing Proprietary Retinal Camera to Market with Vision AI Software • AVAI • Nov 20, 2024 8:00 AM
Geo-Political Tensions and Trump's Increasing Military Budgets Could Boost Demand for Actelis' Cyber Hardened Networking Tech ($ASNS) • ASNS • Nov 19, 2024 10:24 AM
Key Metals Surge, Unlocking New Opportunities for Savvy Mining Investors • GDXJ • Nov 19, 2024 8:45 AM
Greenlane Signs New U.S. Distribution Agreement with Veriteque USA, Manufacturer of the SwabTek™ and Verifique™ Brand of Field Test Kits • GNLN • Nov 19, 2024 8:34 AM